Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657605 · ClinicalTrials.gov registry record · Phase 2
Effects of Human Leptin Replacement
A Phase 2 study of Obesity and Diabetes, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT00657605 is a Phase 2 study of Obesity and Diabetes that has completed, run by University of Miami. The registered enrollment target is 3 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00657605, a Phase 2 study of Obesity and Diabetes, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the hypothesis that leptin contributes to the regulation of the dynamics of human endocrine function.
Conditions Studied
Interventions
- DRUG Recombinant methionyl human leptin
Study Locations (1)
Florida
- University of Miami Miller School of Medicine, Center on Pharmacogenomics - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2001-06 |
| Est. Completion | 2010-05-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00657605
The ClinicalTrials.gov registry entry for NCT00657605 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (100% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Recombinant methionyl human leptin is the first listed.
NCT00657605 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00657605 about?
NCT00657605 is a clinical study titled "Effects of Human Leptin Replacement". This study will test the hypothesis that leptin contributes to the regulation of the dynamics of human endocrine function.
What is the current status of trial NCT00657605?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2001-06. Estimated completion is 2010-05-04.
What conditions does trial NCT00657605 study?
This clinical trial studies the following conditions: Obesity, Diabetes, Metabolic Syndrome.
What interventions are being tested in trial NCT00657605?
The interventions under investigation include: Recombinant methionyl human leptin (DRUG).
Who is sponsoring clinical trial NCT00657605?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00657605 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.